PRKDC and osteosarcoma: To evaluate the influence of DNA‐PKcs expression on the response elicited by anlotinib in osteosarcoma cells, MG63 and U‐2 OS cells were transfected through PRKDC siRNA, followed by treatment with anlotinib.